S56 Controversies in the Diagnosis and Treatment of Male Hypogonadism

Program: Symposia
Basic/Translational Session
Saturday, March 7, 2015: 4:30 PM-6:00 PM
Room 1 (San Diego Convention Center)
**This session is eligible for CME credit**

Shalender Bhasin, MD, Brigham and Women's Hospital-Harvard Medical School, Boston, MA

SB: , Lilly USA, LLC, Principal Investigator, Abbvie, Coinvestigator, Regeneron/ Sanofi, Advisory Group Member, Regeneron/ Sanofi, Founder, FPT, LLC. Disclosure Not Provided: JST
4:30 PM
Alvin M. Matsumoto, MD, GRECC, VA Puget Sound Hlth Care Sys, Seattle, WA
Disclosure: AMM: Principal Investigator, Abbott Laboratories, Principal Investigator, GlaxoSmithKline, Consultant, Abbott Laboratories, Consultant, Lilly USA, LLC, Consultant, Endo Pharmaceuticals, Consultant, Clarus, Editor, Up To Date.
5:00 PM
Robert I McLachlan, MD, PhD, MIMR-PHI Institute of Medical Research, Melbourne, Australia
Nothing to Disclose: RIM
5:30 PM
Shehzad Basaria, M.D., Section on Men's Health, Aging and Metabolism, Brigham and Women's Hospital- Harvard Medical School, Boston, MA
Disclosure: SB: Consultant, Eli Lilly & Company, Principal Investigator, Abbott Laboratories, Consultant, Endo Pharmaceuticals.
See more of: Symposia